To elucidate its anti-HepG2 molecular mechanism, we focused on the effect of C21 steroidal glycosides on ATP1A1 (Figure S1), which is a novel antitumor target of HCC. The gene discussed is ATP1A1; the disease is hepatocellular carcinoma.